Precigen (United States)

Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia

Francesco Paolo Tambaro, Harjeet Singh, Emily Jones et al. · Leukemia · 2021 · 181 citations · Full text

Medicine, Hematology, Oncology +14

Fanconi Anemia Gene Editing by the CRISPR/Cas9 System

Mark J. Osborn, Richard Gabriel, Beau R. Webber et al. · Human Gene Therapy · 2014 · 113 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk

Geun‐Cheol Gil, William H. Velander, Kevin E. Van Cott · Glycobiology · 2008 · 36 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

David A. Sallman, Hany Elmariah, Kendra Sweet et al. · Blood · 2022 · 36 citations

Medicine, Hematology, Oncology +15

A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy

Ahmed O. Hassan, Igor P. Dmitriev, Elena A. Kashentseva et al. · Cell Reports · 2019 · 27 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17